查看購物車
  • English
  • Japanese
  • Korean
全球人口健康管理市場：按組件、功能、交付模式、組織規模、最終用戶和地區分類－預測至2031年
市場調查報告書
商品編碼
2108976

全球人口健康管理市場：按組件、功能、交付模式、組織規模、最終用戶和地區分類－預測至2031年

Population Health Management Market by Component (Software, Services), Functionality (Analytics, Care Management, Risk & Predictive Analytics, VBC), End User (Hospital, Clinic, Payer, Public Health, Employer), Organization Size - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 335 Pages | 訂單完成後即時交付

價格

人口健康管理市場預計將從 2026 年的 469.3 億美元成長到 2031 年的 984.1 億美元，複合年成長率為 16.0%。

市場成長的主要驅動力是醫療保健模式轉向價值導向、慢性病盛行率上升以及在降低醫療成本的同時改善患者療效的迫切需求。醫療服務提供者、保險公司、政府機構和雇主正擴大採用人群健康管理解決方案，以支持識別高風險族群、加強照護協調、慢性病管理和預防性醫療保健措施。透過整合臨床數據、理賠數據、處方數據、實驗室數據和社會健康決定因素 (SDOH) 數據，各機構可以獲得可操作的洞察、改進風險分層並提供個人化護理。

調查範圍
調查期 2026-2031
基準年 2025
預測期 2026-2031
計算單位 金額（10億美元）
部分 按組件、功能、交付方式、組織規模、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

此外，雲端平台、人工智慧 (AI)、預測分析、遠端患者監護和互通醫療保健系統的日益普及，正在提升人群健康管理 (PHM) 能力。隨著醫療機構不斷優先考慮數據驅動的決策、協同照護和基於價值的補償模式，預計在整個預測期內，對綜合性 PHM 解決方案的需求將加速成長。

人口健康管理市場-IMG1

“到2025年，軟體領域將在人口健康管理市場中佔據更大的佔有率。”

從組成來看，人口健康管理市場可分為軟體和服務兩大類。預計到2025年，軟體部分將佔據更大的市場佔有率，這主要得益於用於風險分層、護理管理、預測分析、病人參與和臨床決策支持的人口健康管理平台的普及。醫療服務提供者和保險公司正在增加對軟體解決方案的投資，以整合臨床數據、理賠數據、處方數據和社會健康決定因素（SDOH）數據，從而實現人口規模的即時洞察並改善護理協調。向價值醫療的轉變、基於雲端的人口健康管理平台的日益普及以及對人工智慧驅動的分析和互通性日益成長的需求，都進一步鞏固了軟體部分在人口健康管理市場中的主導地位。

“在預測期內，基於雲端的細分市場預計將呈現最快的成長速度。”

根據交付模式，人口健康管理市場可分為雲端部署、本地部署和混合部署三種模式。其中，雲端部署預計將在預測期內實現最快成長。這一快速成長主要源於對擴充性、經濟高效且可互通的醫療保健解決方案日益成長的需求，這些解決方案能夠支援以價值為導向的醫療服務模式。雲端人口健康管理平台能夠無縫整合臨床數據、理賠數據、配藥數據、實驗室數據和社會健康決定因素 (SDOH) 數據，同時還提供即時分析、遠端患者監護和人工智慧驅動的洞察。其優勢——前期成本低、部署速度快、軟體自動更新以及跨多個醫療機構的安全資料共用——促使醫療服務提供者、保險公司和公共衛生組織廣泛採用雲端部署，使其成為人口健康管理市場中成長最快的細分領域。

“預計亞太地區在預測期內將錄得最高的成長率。”

預計亞太地區在預測期內將實現人口健康管理市場最高的複合年成長率。這一高成長率主要得益於醫療系統的快速數位化、政府主導的促進醫療資訊科技應用的舉措不斷增加、慢性病患病率上升，以及中國、印度、日本、澳洲和韓國等國家對醫療基礎設施投資的增加。電子健康記錄(EHR)、雲端醫療平台、人工智慧分析和遠端患者監護解決方案的日益普及，使醫療機構能夠更好地協調護理工作，並改善當地社區的健康狀況。此外，預防醫學意識的提高、醫療保險覆蓋範圍的擴大以及向價值醫療模式的轉變，都在加速全部區域人口健康管理解決方案的普及，使亞太地區成為預測期內成長最快的區域市場。

Oracle（美國）、Veradigm LLC（美國）、Merative（美國）、Epic Systems Corporation（美國）、Koninklijke Philips NV（荷蘭）、Health Catalyst（美國）和Optum Inc.（美國）是人口健康管理市場的一些領導者。

本研究對這些主要市場參與者進行了詳細的競爭分析，包括公司簡介、近期發展和主要市場策略。

調查範圍

本研究報告按組件（軟體、服務）、功能（人口健康分析、護理管理與協調、風險分層與預測分析、病人參與、醫生參與、基於品質和價值的護理管理、互通性和資料整合等）、交付模式（雲端、本地部署、混合部署）、組織規模（大型企業、中型企業、中小企業）、最終用戶（醫療服務提供者[醫院和醫療系統、診所、其他醫療服務提供者]、健康保險公司[私人保險公司、公共保險公司]、政府和公共衛生機構、雇主、生命科學公司）以及地區（北美、歐洲、亞太、拉丁美洲、中東和非洲）對人口健康管理市場進行細分。本報告涵蓋影響人口健康管理市場成長的關鍵因素（促進因素、阻礙因素、挑戰、機會等）的詳細資訊。本報告對主要行業參與者進行了詳細分析，深入探討了他們的業務概況、軟體、服務、關鍵策略以及與人口健康管理市場相關的最新發展，包括合約、夥伴關係、協議、新產品和服務發布、併購以及其他相關資訊。該報告還對人口健康管理市場生態系統中的新興企業企業和成熟企業進行了競爭分析。

購買本報告的理由

本報告為市場領導和新參與企業提供人口健康管理市場及其細分市場最準確的收入預測。它幫助相關人員了解競爭格局，更好地定位自身業務，並深入了解市場動態，從而製定合適的打入市場策略。此外，本報告還幫助相關人員了解市場趨勢，並提供關鍵市場促進因素、限制因素、挑戰和機會的資訊。

本報告深入分析了以下幾點：

  • 本報告深入分析了影響人口健康管理市場成長的因素，包括對關鍵促進因素（基於價值的醫療保健 (VBC) 和基於風險的報銷模式的擴展、越來越重視通過協作醫療保健減少再入院、在醫療保健環境中擴大採用人工智慧驅動的預測分析以及互通性操作數字健康數據的可用性提高）、阻礙因素因素（健康數據納入人口健康策略、遠端患者監護和虛擬護理計劃的擴展以及對人工智慧驅動的自動化護理管理的需求不斷成長）和挑戰（證明可衡量的投資回報率 (ROI)、整合到臨床工作流程中以及用戶特定的採用情況）的分析。
  • 產品開發/創新：深入了解人口健康管理市場的未來技術、研發活動以及新產品/服務的推出。
  • 市場發展：提供盈利市場的全面資訊。本報告分析了不同地區的人口健康管理市場。
  • 市場多元化：全面介紹人口健康管理市場的新產品和服務、未開發的市場、近期趨勢和投資情況。
  • 競爭分析：對人口健康管理市場主要參與者的市場佔有率、成長策略以及軟體產品和服務進行詳細評估，包括 Oracle（美國）、Veradigm LLC（美國）、Merative（美國）、Epic Systems Corporation（美國）、Koninklijke Philips NV（荷蘭）、i2i Population Health（美國）、Health Catalyst（美國）和 Catalyst（美國）。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和未開發的領域
  • 相互關聯的市場與跨產業機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 宏觀經濟指標
  • 價值鏈分析
  • 生態系分析
  • 價格分析
  • 2026-2027 年主要會議和活動
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措場景
  • 案例研究分析
  • 2025年美國關稅的影響－人口健康管理市場

第6章：透過採用技術、專利、數位技術和人工智慧實現策略顛覆

  • 主要新興技術
  • 互補技術
  • 鄰近技術
  • 技術/產品藍圖
  • 專利分析
  • 未來應用
  • 人工智慧/生成式人工智慧對人口健康管理市場的影響

第7章 監理情勢

  • 當地法規和合規性
    • 監管機構、政府機構和其他組織
    • 法規結構
    • 業界標準

第8章：顧客趨勢與購買行為

  • 決策流程
  • 主要相關人員和採購評估標準
  • 實施障礙和內部挑戰
  • 來自不同終端使用者的未滿足需求
  • 市場盈利

第9章 人口健康管理市場（按組成部分）

  • 軟體
  • 服務

第10章 人口健康管理市場（依功能分類）

  • 人口健康分析
  • 護理管理與護理協調
  • 風險分層和預測分析
  • 患者參與
  • 醫生的參與
  • 以品質和價值為導向的醫療管理
  • 互通性和資料整合
  • 其他

第11章 人口健康管理市場（依交付模式分類）

  • 基於雲端的
  • 現場
  • 混合

第12章 人口健康管理市場（依機構規模分類）

  • 大公司
  • 中型公司
  • 小型企業

第13章 人口健康管理市場（依最終用戶分類）

  • 醫護人員
  • 醫療費用支付方
  • 政府機構和公共衛生機構
  • 雇主
  • 生命科學

第14章 人口健康管理市場（依地區分類）

  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太地區宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 中東和非洲宏觀經濟展望
    • 海灣合作理事會國家
    • 南非
    • 其他

第15章 競爭格局

  • 主要參與企業的策略/優勢
  • 2021-2025年所得分配分析
  • 2025年市佔率分析
  • 企業估值矩陣：主要公司，2025 年
  • 公司估值矩陣：新創企業/中小企業，2025 年
  • 企業估值和財務指標
  • 品牌/軟體比較分析
  • 競爭格局

第16章：公司簡介

  • 主要參與企業
    • ORACLE
    • OPTUM, INC.
    • KONINKLIJKE PHILIPS NV
    • EPIC SYSTEMS CORPORATION
    • MERATIVE
    • VERADIGM LLC
    • I2I POPULATION HEALTH
    • HEALTH CATALYST
    • CEDAR GATE TECHNOLOGIES
    • ECLINICALWORKS
    • ELLIGINT HEALTH
    • MEDECISION
    • ARCADIA
    • ATHENAHEALTH
    • COTIVITI, INC.
    • NXGN MANAGEMENT, LLC.（NEXTGEN HEALTHCARE）
  • 其他公司
    • MEDEANALYTICS, INC.
    • CONIFER HEALTH SOLUTIONS
    • LIGHTBEAM HEALTH SOLUTIONS
    • INNOVACCER
    • LUMERIS
    • ZEOMEGA
    • MILLIMAN MEDINSIGHT（A MILLIMAN COMPANY）
    • PERSIVIA
    • COLOR HEALTH, INC.

第17章調查方法

第18章附錄

Product Code: HIT 2429

The population health management market is projected to reach USD 98.41 billion by 2031 from USD 46.93 billion in 2026, at a CAGR of 16.0%. Market growth is primarily driven by the increasing shift toward value-based care, the rising prevalence of chronic diseases, and the growing need to improve patient outcomes while reducing healthcare costs. Healthcare providers, payers, government agencies, and employers are increasingly adopting population health management solutions to identify high-risk populations, enhance care coordination, manage chronic conditions, and support preventive care initiatives. The integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data enables organizations to generate actionable insights, improve risk stratification, and deliver personalized care.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsComponent, Functionality, Delivery Mode, Organization Size, End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Additionally, the growing adoption of cloud-based platforms, artificial intelligence (AI), predictive analytics, remote patient monitoring, and interoperable healthcare systems is strengthening population health management capabilities. As healthcare organizations continue to prioritize data-driven decision-making, care coordination, and value-based reimbursement models, demand for comprehensive PHM solutions is expected to accelerate throughout the forecast period.

Population Health Management Market - IMG1

"The software segment accounted for a larger share of the population health management market in 2025."

Based on component, the population health management market has been segmented into software and services. The software segment accounted for a larger market share in 2025, driven by the widespread adoption of population health platforms for risk stratification, care management, predictive analytics, patient engagement, and clinical decision support. Healthcare providers and payers are increasingly investing in software solutions to integrate clinical, claims, pharmacy, and social determinants of health (SDOH) data, enabling real-time population insights and improved care coordination. The growing transition toward value-based care, increasing adoption of cloud-based PHM platforms, and rising demand for AI-enabled analytics and interoperability have further strengthened the dominance of the software segment in the population health management market.

"The cloud-based segment is expected to exhibit the fastest growth during the forecast period."

Based on delivery mode, the population health management market has been segmented into cloud-based, on-premises, and hybrid models. Of these, the cloud-based segment is expected to record the fastest growth during the forecast period. This fast-paced growth is mainly driven by the increasing demand for scalable, cost-effective, and interoperable healthcare solutions that support value-based care initiatives. Cloud-based PHM platforms enable seamless integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data while providing real-time analytics, remote patient monitoring, and AI-driven insights. Their lower upfront costs, faster deployment, automatic software updates, and ability to securely share data across multiple care settings are encouraging widespread adoption among healthcare providers, payers, and public health organizations, making cloud-based deployment the fastest-growing segment in the population health management market.

"Asia Pacific is expected to register the highest growth rate during the forecast period."

Asia Pacific is expected to witness the highest CAGR in the population health management market during the forecast period. This high growth rate is mainly supported by the rapid digitalization of healthcare systems, increasing government initiatives promoting healthcare IT adoption, rising prevalence of chronic diseases, and expanding investments in healthcare infrastructure across countries such as China, India, Japan, Australia, and South Korea. The growing adoption of electronic health records (EHRs), cloud-based healthcare platforms, AI-powered analytics, and remote patient monitoring solutions is enabling healthcare organizations to improve care coordination and population health outcomes. Furthermore, increasing awareness of preventive healthcare, expanding health insurance coverage, and the transition toward value-based care are accelerating the adoption of population health management solutions across the region, making Asia Pacific the fastest-growing regional market during the forecast period.

The breakdown of primary participants is as given below:

  • By Company Type - Tier 1: 37%, Tier 2: 22%, and Tier 3: 41%
  • By Designation - C-level: 55%, Director-level: 20%, and Others: 25%
  • By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Latin America: 3%, Middle East & Africa: 2%

Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), Health Catalyst (US), and Optum Inc. (US) are some of the key players in the population health management market.

The study includes an in-depth competitive analysis of these key market players, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the population health management market by component (Software, Services), functionality (Population Health Analytics, Care Management & Care Coordination, Risk Stratification & Predictive Analytics, Patient Engagement, Physician Engagement, Quality & Value-based Care Management, Interoperability & Data Integration, Others), delivery mode (Cloud-based, On-premises, Hybrid), organization size (Large Enterprises, Medium Enterprises, Small Enterprises), end user (Healthcare Providers [Hospitals & Health Systems, Physician Practices & Clinics, Other Healthcare Providers], Healthcare Payers [Private Payers, Public Payers], Government & Public Health Agencies, Employers, Life Sciences), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the population health management market. A detailed analysis of the key industry players has been done to provide insights into their business overview, software, and services; key strategies; and contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the population health management market. Competitive analysis of upcoming and established players in the population health management market ecosystem is covered in this report.

Reasons to Buy this Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the population health management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • The report provides insights on the following pointers: Analysis of key drivers (Expansion of Value-based Care (VBC) and Risk-based Reimbursement Models, Growing Focus on Reducing Hospital Readmissions through Coordinated Care, Growing Adoption of AI-Driven Predictive Analytics within Healthcare Organizations, Increasing Availability of Interoperable Digital Health Data), restraints (Persistent Healthcare Data Interoperability Challenges, Rising Data Breach Concerns), opportunities (Integration of Social Determinants of Health (SDOH) into Population Health Strategies, Expansion of Remote Patient Monitoring and Virtual Care Programs, Growing Demand for AI-powered Care Management Automation), and challenges (Demonstrating Measurable Return on Investment (ROI), Clinical Workflow Integration and User Adoption) influencing the growth of the population health management market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the population health management market
  • Market Development: Comprehensive information about lucrative markets; the report analyses the population health management market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the population health management market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and software offerings of leading players like Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), i2i Population Health (US), Health Catalyst (US), and Optum Inc. (US), among others, in the population health management market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
  • 3.2 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT AND REGION
  • 3.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Expansion of value-based care (VBC) and risk-based reimbursement models
      • 4.2.1.2 Growing focus on reducing hospital readmissions through coordinated care
      • 4.2.1.3 Growing adoption of AI-driven predictive analytics within healthcare organizations
      • 4.2.1.4 Increasing availability of interoperable digital health data
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Persistent healthcare data interoperability challenges
      • 4.2.2.2 Rising data breach concerns
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Integration of Social Determinants of Health (SDOH) into population health strategies
      • 4.2.3.2 Expansion of remote patient monitoring and virtual care programs
      • 4.2.3.3 Growing demand for AI-powered care management automation
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Demonstrating measurable return on investment
      • 4.2.4.2 Clinical workflow integration and user adoption
  • 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 THREAT OF NEW ENTRANTS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.3.2 TECHNOLOGY INPUTS & INFRASTRUCTURE
    • 5.3.3 PLATFORM DEVELOPMENT & INTEGRATION
    • 5.3.4 DISTRIBUTION
    • 5.3.5 MARKETING & SALES
    • 5.3.6 POST-SALES SERVICES
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY COMPONENT (2025)
    • 5.5.2 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION (2025)
  • 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 CASE STUDY ANALYSIS
  • 5.10 IMPACT OF 2025 US TARIFF - POPULATION HEALTH MANAGEMENT MARKET
    • 5.10.1 INTRODUCTION
    • 5.10.2 KEY TARIFF RATES
    • 5.10.3 PRICE IMPACT ANALYSIS
    • 5.10.4 IMPACT ON COUNTRY/REGION
      • 5.10.4.1 US
      • 5.10.4.2 Europe
      • 5.10.4.3 Asia Pacific
    • 5.10.5 IMPACT ON END USERS
      • 5.10.5.1 Healthcare providers
      • 5.10.5.2 Healthcare payers
      • 5.10.5.3 Government & public health agencies
      • 5.10.5.4 Employers
      • 5.10.5.5 Life sciences

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 AI-POWERED PREDICTIVE ANALYTICS & RISK STRATIFICATION
    • 6.1.2 GENERATIVE AI & CLINICAL DECISION SUPPORT
    • 6.1.3 DIGITAL CARE MANAGEMENT & REMOTE PATIENT MONITORING (RPM)
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 EHR, EMR, AND CLINICAL WORKFLOW INTEGRATION
    • 6.2.2 HEALTHCARE DATA PLATFORMS & INTEROPERABILITY (FHIR, HL7, APIS)
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 VALUE-BASED CARE & CARE COORDINATION PLATFORMS
    • 6.3.2 SOCIAL DETERMINANTS OF HEALTH (SDOH) & COMMUNITY HEALTH PLATFORMS
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 PATENT PUBLICATION TRENDS FOR POPULATION HEALTH MANAGEMENT MARKET
    • 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 PRECISION POPULATION HEALTH & AI-DRIVEN RISK PREDICTION
    • 6.6.2 CONTINUOUS CARE ECOSYSTEMS THROUGH REMOTE MONITORING & DIGITAL THERAPEUTICS
    • 6.6.3 SOCIAL DETERMINANTS OF HEALTH (SDOH) INTELLIGENCE & COMMUNITY-BASED CARE ORCHESTRATION
  • 6.7 IMPACT OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT MARKET
    • 6.7.1 INTRODUCTION
    • 6.7.2 MARKET POTENTIAL OF AI/GEN AI IN POPULATION HEALTH MANAGEMENT
    • 6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
      • 6.7.3.1 AI-powered claims management and revenue cycle optimization at Sentara Health
    • 6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 6.7.4.1 Healthcare analytics market
      • 6.7.4.2 Healthcare interoperability market
      • 6.7.4.3 Remote patient monitoring market
    • 6.7.5 USER READINESS AND IMPACT ASSESSMENT
      • 6.7.5.1 User readiness
        • 6.7.5.1.1 Healthcare providers
        • 6.7.5.1.2 Healthcare payers
      • 6.7.5.2 Impact assessment
        • 6.7.5.2.1 User A: Healthcare providers
        • 6.7.5.2.2 User B: Healthcare payers

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATORY FRAMEWORK
      • 7.1.2.1 North America
      • 7.1.2.2 Europe
      • 7.1.2.3 Asia Pacific
      • 7.1.2.4 Latin America
      • 7.1.2.5 Middle East & Africa
    • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 INTRODUCTION
  • 8.2 DECISION-MAKING PROCESS
  • 8.3 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.3.2 BUYING CRITERIA
  • 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.5 UNMET NEEDS FROM VARIOUS END USERS
    • 8.5.1 UNMET NEEDS
    • 8.5.2 END-USER EXPECTATIONS
  • 8.6 MARKET PROFITABILITY

9 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT

  • 9.1 INTRODUCTION
  • 9.2 SOFTWARE
    • 9.2.1 AI-POWERED ANALYTICS PLATFORMS PROPEL PHM SOFTWARE ADOPTION ACROSS VALUE-BASED ECOSYSTEMS
  • 9.3 SERVICES
    • 9.3.1 MANAGED CARE COORDINATION SERVICES BRIDGE TECHNOLOGY GAPS ACROSS FRAGMENTED HEALTH SYSTEMS

10 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY

  • 10.1 INTRODUCTION
  • 10.2 POPULATION HEALTH ANALYTICS
    • 10.2.1 REAL-WORLD DATA INTEGRATION FUELS ACTIONABLE ANALYTICS ACROSS ENTIRE PATIENT POPULATIONS
  • 10.3 CARE MANAGEMENT & CARE COORDINATION
    • 10.3.1 ACO EXPANSION AND RISK-BEARING PAYMENT MODELS DRIVE INVESTMENT
  • 10.4 RISK STRATIFICATION & PREDICTIVE ANALYTICS
    • 10.4.1 PREDICTIVE AI MODELS ENABLE EARLIER INTERVENTION AND PRECISION RISK MANAGEMENT AT SCALE
  • 10.5 PATIENT ENGAGEMENT
    • 10.5.1 DIGITAL PATIENT ACTIVATION PROGRAMS CLOSE CARE GAPS AND IMPROVE CHRONIC DISEASE OUTCOMES
  • 10.6 PHYSICIAN ENGAGEMENT
    • 10.6.1 CLINICAL DECISION SUPPORT AND QUALITY DASHBOARDS EMBEDDING PHM INTO DAILY PHYSICIAN WORKFLOWS
  • 10.7 QUALITY & VALUE-BASED CARE MANAGEMENT
    • 10.7.1 RECORD ACO SAVINGS AND EXPANDED VBC INCENTIVES ACCELERATE QUALITY MANAGEMENT PLATFORM ADOPTION
  • 10.8 INTEROPERABILITY & DATA INTEGRATION
    • 10.8.1 TEFCA EXPANSION AND FHIR STANDARDS STRENGTHENING INFRASTRUCTURE FOR PHM DATA EXCHANGE
  • 10.9 OTHER FUNCTIONALITIES
    • 10.9.1 PUBLIC HEALTH SURVEILLANCE MODERNIZATION AND SDOH INTEGRATION EXPAND MARKET BOUNDARIES

11 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE

  • 11.1 INTRODUCTION
  • 11.2 CLOUD-BASED
    • 11.2.1 INTEROPERABILITY MANDATES AND VBC SCALABILITY DEMANDS CEMENT CLOUD AS DOMINANT DELIVERY MODEL
  • 11.3 ON-PREMISES
    • 11.3.1 DATA SOVEREIGNTY, LEGACY INTEGRATION, AND REGULATORY COMPLIANCE SUSTAIN ON-PREMISES DEPLOYMENT
  • 11.4 HYBRID
    • 11.4.1 CLINICAL DATA CONTROL AND ANALYTICS SCALABILITY BALANCED THROUGH INTEGRATED HYBRID ARCHITECTURES

12 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE

  • 12.1 INTRODUCTION
  • 12.2 LARGE ENTERPRISES
    • 12.2.1 ENTERPRISE-WIDE DIGITAL TRANSFORMATION AND VALUE-BASED CARE INITIATIVES DRIVE MARKET LEADERSHIP
  • 12.3 MEDIUM ENTERPRISES
    • 12.3.1 INCREASING PARTICIPATION IN VALUE-BASED CARE DRIVES DEMAND FOR SCALABLE PHM SOLUTIONS
  • 12.4 SMALL ENTERPRISES
    • 12.4.1 SUBSCRIPTION-BASED DEPLOYMENT MODELS IMPROVE PHM ACCESSIBILITY AND MARKET PENETRATION

13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER

  • 13.1 INTRODUCTION
  • 13.2 HEALTHCARE PROVIDERS
    • 13.2.1 HOSPITALS & HEALTH SYSTEMS
      • 13.2.1.1 Hospital digital transformation programs accelerate enterprise PHM platform deployment
    • 13.2.2 PHYSICIAN PRACTICES & CLINICS
      • 13.2.2.1 Independent practice value-based contracting creating scaled demand
    • 13.2.3 OTHER HEALTHCARE PROVIDERS
      • 13.2.3.1 Post-acute, behavioral health, and FQHC providers expand PHM market reach
  • 13.3 HEALTHCARE PAYERS
    • 13.3.1 RISK-BASED CONTRACTING EXPANSION AND CHRONIC DISEASE COST BURDEN DRIVE SEGMENT
    • 13.3.2 PRIVATE PAYERS
      • 13.3.2.1 Commercial VBC contracts and rising employer premiums accelerate adoption
    • 13.3.3 PUBLIC PAYERS
      • 13.3.3.1 CMS ACO expansion and Medicaid managed care growth reshaping public payer infrastructure
  • 13.4 GOVERNMENT & PUBLIC HEALTH AGENCIES
    • 13.4.1 PUBLIC HEALTH DATA MODERNIZATION AND GLOBAL DIGITAL HEALTH PROGRAMS BOOST GROWTH
  • 13.5 EMPLOYERS
    • 13.5.1 ESCALATING HEALTH BENEFIT COSTS AND CHRONIC DISEASE BURDEN COMPELLING EMPLOYER PHM PROGRAM INVESTMENT
  • 13.6 LIFE SCIENCES
    • 13.6.1 REAL-WORLD EVIDENCE GENERATION AND PATIENT RECRUITMENT DRIVE PHM PLATFORM ADOPTION

14 POPULATION HEALTH MANAGEMENT MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 14.2.2 US
      • 14.2.2.1 Value-based care and digital health transformation drive population health management adoption
    • 14.2.3 CANADA
      • 14.2.3.1 Digital health modernization & interoperability accelerate market growth
  • 14.3 EUROPE
    • 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 14.3.2 GERMANY
      • 14.3.2.1 Health data utilization and digital care reforms advance population health management
    • 14.3.3 FRANCE
      • 14.3.3.1 National health data ecosystem and preventive healthcare accelerates market growth
    • 14.3.4 UK
      • 14.3.4.1 Integrated care systems and population health analytics transforming healthcare delivery
    • 14.3.5 ITALY
      • 14.3.5.1 Community healthcare transformation and digital care continuity strengthen market growth
    • 14.3.6 SPAIN
      • 14.3.6.1 Regional integrated care networks and chronic disease management drives market expansion
    • 14.3.7 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 14.4.2 CHINA
      • 14.4.2.1 Healthy China 2030 and AI-driven healthcare transformation accelerate market growth
    • 14.4.3 JAPAN
      • 14.4.3.1 Healthy aging and community-based integrated care drive healthcare transformation
    • 14.4.4 INDIA
      • 14.4.4.1 Ayushman Bharat and digital public health infrastructure drive integrated care delivery
    • 14.4.5 AUSTRALIA
      • 14.4.5.1 Primary healthcare networks and digital health initiatives drive preventive care
    • 14.4.6 SOUTH KOREA
      • 14.4.6.1 AI-enabled healthcare and digital health innovation drive personalized care
    • 14.4.7 REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    • 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 14.5.2 BRAZIL
      • 14.5.2.1 National Health Data Network (RNDS) and digital health transformation strengthen market
    • 14.5.3 MEXICO
      • 14.5.3.1 Electronic health record standardization and healthcare digitalization support market growth
    • 14.5.4 REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST & AFRICA
    • 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 14.6.2 GCC COUNTRIES
      • 14.6.2.1 Saudi Arabia
        • 14.6.2.1.1 Vision 2030 and AI-enabled healthcare transformation advancing population health management
      • 14.6.2.2 UAE
        • 14.6.2.2.1 AI-driven healthcare and national health data platforms accelerating population health management
      • 14.6.2.3 Other GCC countries
        • 14.6.2.3.1 National healthcare diversification creating opportunities for population health management
    • 14.6.3 SOUTH AFRICA
      • 14.6.3.1 National health insurance and primary healthcare reforms drive market
    • 14.6.4 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

  • 15.1 INTRODUCTION
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET
  • 15.3 REVENUE SHARE ANALYSIS, 2021-2025
  • 15.4 MARKET SHARE ANALYSIS, 2025
  • 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.5.1 STARS
    • 15.5.2 PERVASIVE PLAYERS
    • 15.5.3 EMERGING LEADERS
    • 15.5.4 PARTICIPANTS
    • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.5.5.1 Company footprint
      • 15.5.5.2 Region footprint
      • 15.5.5.3 Component footprint
      • 15.5.5.4 Functionality footprint
      • 15.5.5.5 Delivery mode footprint
      • 15.5.5.6 End user footprint
  • 15.6 COMPANY EVALUATION MATRIX: STARTUPS /SMES, 2025
    • 15.6.1 PROGRESSIVE COMPANIES
    • 15.6.2 DYNAMIC COMPANIES
    • 15.6.3 STARTING BLOCKS
    • 15.6.4 RESPONSIVE COMPANIES
    • 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
  • 15.7 COMPANY VALUATION & FINANCIAL METRICS
    • 15.7.1 FINANCIAL METRICS
    • 15.7.2 COMPANY VALUATION
  • 15.8 BRAND/SOFTWARE COMPARISON ANALYSIS
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES & DEVELOPMENTS
    • 15.9.2 DEALS
    • 15.9.3 OTHER DEVELOPMENTS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 ORACLE
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product launches & approvals
        • 16.1.1.3.2 Deals
        • 16.1.1.3.3 Other developments
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses & competitive threats
    • 16.1.2 OPTUM, INC.
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Deals
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses & competitive threats
    • 16.1.3 KONINKLIJKE PHILIPS N.V.
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product launches & approvals
        • 16.1.3.3.2 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses & competitive threats
    • 16.1.4 EPIC SYSTEMS CORPORATION
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Product launches & approvals
        • 16.1.4.3.2 Deals
      • 16.1.4.4 MnM view
        • 16.1.4.4.1 Right to win
        • 16.1.4.4.2 Strategic choices
        • 16.1.4.4.3 Weaknesses & competitive threats
    • 16.1.5 MERATIVE
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Deals
        • 16.1.5.3.2 Expansions
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses & competitive threats
    • 16.1.6 VERADIGM LLC
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Deals
        • 16.1.6.3.2 Other developments
    • 16.1.7 I2I POPULATION HEALTH
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Deals
    • 16.1.8 HEALTH CATALYST
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Product launches & approvals
        • 16.1.8.3.2 Deals
    • 16.1.9 CEDAR GATE TECHNOLOGIES
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Product launches & approvals
    • 16.1.10 ECLINICALWORKS
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Product launches & approvals
    • 16.1.11 ELLIGINT HEALTH
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products offered
    • 16.1.12 MEDECISION
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products offered
      • 16.1.12.3 Recent developments
        • 16.1.12.3.1 Product launches & approvals
        • 16.1.12.3.2 Deals
    • 16.1.13 ARCADIA
      • 16.1.13.1 Business overview
      • 16.1.13.2 Products offered
      • 16.1.13.3 Recent developments
        • 16.1.13.3.1 Deals
    • 16.1.14 ATHENAHEALTH
      • 16.1.14.1 Business overview
      • 16.1.14.2 Products offered
      • 16.1.14.3 Recent developments
        • 16.1.14.3.1 Deals
    • 16.1.15 COTIVITI, INC.
      • 16.1.15.1 Business overview
      • 16.1.15.2 Products offered
      • 16.1.15.3 Recent developments
        • 16.1.15.3.1 Deals
        • 16.1.15.3.2 Other developments
    • 16.1.16 NXGN MANAGEMENT, LLC. (NEXTGEN HEALTHCARE)
      • 16.1.16.1 Business overview
      • 16.1.16.2 Products offered
  • 16.2 OTHER PLAYERS
    • 16.2.1 MEDEANALYTICS, INC.
    • 16.2.2 CONIFER HEALTH SOLUTIONS
    • 16.2.3 LIGHTBEAM HEALTH SOLUTIONS
    • 16.2.4 INNOVACCER
    • 16.2.5 LUMERIS
    • 16.2.6 ZEOMEGA
    • 16.2.7 MILLIMAN MEDINSIGHT (A MILLIMAN COMPANY)
    • 16.2.8 PERSIVIA
    • 16.2.9 COLOR HEALTH, INC.

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH APPROACH
    • 17.1.1 SECONDARY RESEARCH
      • 17.1.1.1 Key data from secondary sources
    • 17.1.2 PRIMARY RESEARCH
      • 17.1.2.1 Primary sources
      • 17.1.2.2 Key data from primary sources
      • 17.1.2.3 Breakdown of primaries
      • 17.1.2.4 Insights from primary experts
  • 17.2 RESEARCH METHODOLOGY
  • 17.3 MARKET SIZE ESTIMATION
  • 17.4 MARKET BREAKDOWN DATA TRIANGULATION
  • 17.5 MARKET SHARE ESTIMATION
  • 17.6 STUDY ASSUMPTIONS
  • 17.7 RESEARCH LIMITATIONS
    • 17.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 17.8 RISK ASSESSMENT

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 EXCHANGE RATES USED FOR CONVERSION TO USD
  • TABLE 2 US: BIGGEST HEALTHCARE DATA BREACHES OF 2025
  • TABLE 3 HEALTHCARE EDI MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 POPULATION HEALTH MANAGEMENT MARKET: ROLE IN ECOSYSTEM
  • TABLE 5 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY COMPONENT (2025)
  • TABLE 6 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION (2025)
  • TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 8 CASE 1: ACCELERATED VALUE-BASED CARE DELIVERY WITH AI-DRIVEN POPULATION HEALTH MANAGEMENT
  • TABLE 9 CASE 2: IMPROVED COMMUNITY HEALTH THROUGH DATA-DRIVEN POPULATION HEALTH ANALYTICS
  • TABLE 10 CASE 3: REDUCED EMERGENCY DEPARTMENT VISITS THROUGH AI-ENABLED POPULATION HEALTH MANAGEMENT
  • TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR POPULATION HEALTH MANAGEMENT MARKET
  • TABLE 13 POPULATION HEALTH MANAGEMENT MARKET: KEY PATENTS/PATENT APPLICATIONS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA
  • TABLE 20 REGULATORY SCENARIO OF EUROPE
  • TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC
  • TABLE 22 REGULATORY SCENARIO OF LATIN AMERICA
  • TABLE 23 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
  • TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 26 UNMET NEEDS IN POPULATION HEALTH MANAGEMENT MARKET
  • TABLE 27 END-USER EXPECTATIONS IN POPULATION HEALTH MANAGEMENT MARKET
  • TABLE 28 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 29 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 30 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 31 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 32 POPULATION HEALTH ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 33 CARE MANAGEMENT & CARE COORDINATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 34 RISK STRATIFICATION & PREDICTIVE ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 35 PATIENT ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 36 PHYSICIAN ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 37 QUALITY & VALUE-BASED CARE MANAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 38 INTEROPERABILITY & DATA INTEGRATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 39 OTHER FUNCTIONALITIES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 40 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 41 CLOUD-BASED: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 42 ON-PREMISES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 43 HYBRID: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 44 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 45 POPULATION HEALTH MANAGEMENT MARKET FOR LARGE ENTERPRISES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 46 POPULATION HEALTH MANAGEMENT MARKET FOR MEDIUM ENTERPRISES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 47 POPULATION HEALTH MANAGEMENT MARKET FOR SMALL ENTERPRISES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 48 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 49 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 50 HEALTHCARE PROVIDERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 51 POPULATION HEALTH MANAGEMENT MARKET FOR HOSPITALS AND HEALTH SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 52 POPULATION HEALTH MANAGEMENT MARKET FOR PHYSICIAN PRACTICES & CLINICS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 53 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 54 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 55 HEALTHCARE PAYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 56 POPULATION HEALTH MANAGEMENT MARKET FOR PRIVATE PAYERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 57 POPULATION HEALTH MANAGEMENT MARKET FOR PUBLIC PAYERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 58 GOVERNMENT & PUBLIC HEALTH AGENCIES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 59 EMPLOYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 60 LIFE SCIENCES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 61 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 62 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 64 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 65 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 66 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 68 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 69 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 70 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 71 US: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 72 US: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 73 US: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 74 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 75 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 76 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 77 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 78 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 79 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 80 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 81 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 82 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 83 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 84 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 86 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 87 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 88 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 89 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 90 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 91 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 92 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 93 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 94 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 95 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 96 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 97 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 98 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 99 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 100 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 101 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 102 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 103 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 104 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 105 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 106 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 107 UK: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 108 UK: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 109 UK: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 110 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 111 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 112 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 113 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 114 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 115 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 116 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 117 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 118 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 119 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 120 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 121 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 122 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 123 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 124 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 125 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 126 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 127 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 128 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 129 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 130 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 131 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 132 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 133 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 142 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 143 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 144 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 145 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 146 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 147 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 148 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 149 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 150 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 151 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 152 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 153 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 154 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 155 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 156 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 157 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 158 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 159 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 160 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 161 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 162 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 163 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 164 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 165 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 166 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 167 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 168 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 169 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 170 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 171 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 172 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 173 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 174 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 175 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 176 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 184 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 185 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 186 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 187 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 188 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 189 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 190 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 191 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 192 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 193 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 194 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 195 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 196 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 197 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 198 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 199 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 200 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 201 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 202 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 203 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 204 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 205 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 206 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 207 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 209 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 213 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 221 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 229 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 230 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 231 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 232 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 233 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 234 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 235 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 236 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 237 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 238 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 239 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 240 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 241 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 242 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 243 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 244 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 245 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 246 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 247 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 248 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 249 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 250 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 251 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 252 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 253 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 254 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 255 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 256 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 257 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 258 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 259 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 260 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 261 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 262 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 263 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 264 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
  • TABLE 265 POPULATION HEALTH MANAGEMENT MARKET: DEGREE OF COMPETITION
  • TABLE 266 POPULATION HEALTH MANAGEMENT MARKET: REGION FOOTPRINT
  • TABLE 267 POPULATION HEALTH MANAGEMENT MARKET: COMPONENT FOOTPRINT
  • TABLE 268 POPULATION HEALTH MANAGEMENT MARKET: FUNCTIONALITY ANALYSIS
  • TABLE 269 POPULATION HEALTH MANAGEMENT MARKET: DELIVERY MODE FOOTPRINT
  • TABLE 270 END USER FOOTPRINT ANALYSIS
  • TABLE 271 POPULATION HEALTH MANAGEMENT MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 272 KEY EMERGING PLAYERS/STARTUPS: REGION FOOTPRINT
  • TABLE 273 KEY EMERGING PLAYERS/STARTUPS: COMPONENT FOOTPRINT
  • TABLE 274 KEY EMERGING PLAYERS/STARTUPS: FUNCTIONALITY FOOTPRINT
  • TABLE 275 KEY EMERGING PLAYERS/STARTUPS: DELIVERY MODE FOOTPRINT
  • TABLE 276 KEY EMERGING PLAYERS/STARTUPS: END USER FOOTPRINT
  • TABLE 277 POPULATION HEALTH MANAGEMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 278 POPULATION HEALTH MANAGEMENT MARKET: DEALS, JANUARY 2023-JULY 2026
  • TABLE 279 POPULATION HEALTH MANAGEMENT MARKET: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 280 ORACLE: COMPANY OVERVIEW
  • TABLE 281 ORACLE: PRODUCTS OFFERED
  • TABLE 282 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 283 ORACLE: DEALS, JANUARY 2023-JULY 2026
  • TABLE 284 ORACLE: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 285 OPTUM INC.: COMPANY OVERVIEW
  • TABLE 286 OPTUM, INC.: PRODUCTS OFFERED
  • TABLE 287 OPTUM, INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 288 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 289 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 290 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 291 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 292 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 293 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED
  • TABLE 294 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 295 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023-JULY 2026
  • TABLE 296 MERATIVE: COMPANY OVERVIEW
  • TABLE 297 MERATIVE: PRODUCTS OFFERED
  • TABLE 298 MERATIVE: DEALS, JANUARY 2023-JULY2026
  • TABLE 299 MERATIVE: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 300 VERADIGM LLC: COMPANY OVERVIEW
  • TABLE 301 VERADIGM LLC: PRODUCTS OFFERED
  • TABLE 302 VERADIGM LLC: DEALS, JANUARY 2023-JULY 2026
  • TABLE 303 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 304 I2I POPULATION HEALTH: COMPANY OVERVIEW
  • TABLE 305 I2I POPULATION HEALTH: PRODUCTS OFFERED
  • TABLE 306 I2I POPULATION HEALTH: DEALS, JANUARY 2023-JULY 2026
  • TABLE 307 HEALTH CATALYST: COMPANY OVERVIEW
  • TABLE 308 HEALTH CATALYST: PRODUCTS OFFERED
  • TABLE 309 HEALTH CATALYST: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 310 HEALTH CATALYST: DEALS, JANUARY 2023-JULY 2026
  • TABLE 311 CEDAR GATE TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 312 CEDAR GATE TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 313 CEDAR GATE TECHNOLOGIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 314 ECLINICALWORKS: COMPANY OVERVIEW
  • TABLE 315 ECLINICALWORKS: PRODUCTS OFFERED
  • TABLE 316 ECLINICALWORKS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 317 ELLIGINT HEALTH: COMPANY OVERVIEW
  • TABLE 318 ELLIGINT HEALTH: PRODUCTS OFFERED
  • TABLE 319 MEDECISION: COMPANY OVERVIEW
  • TABLE 320 MEDECISION: PRODUCTS OFFERED
  • TABLE 321 MEDECISION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 322 MEDECISION: DEALS, JANUARY 2023-JULY 2026
  • TABLE 323 ARCADIA: COMPANY OVERVIEW
  • TABLE 324 ARCADIA: PRODUCTS OFFERED
  • TABLE 325 ARCADIA: DEALS, JANUARY 2023-JULY 2026
  • TABLE 326 ATHENAHEALTH: COMPANY OVERVIEW
  • TABLE 327 ATHENAHEALTH: PRODUCTS OFFERED
  • TABLE 328 ATHENAHEALTH: DEALS, JANUARY 2023-JULY 2026
  • TABLE 329 COTIVITI, INC.: COMPANY OVERVIEW
  • TABLE 330 COTIVITI, INC.: PRODUCTS OFFERED
  • TABLE 331 COTIVITI, INC.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 332 COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 333 NXGN MANAGEMENT, LLC.: COMPANY OVERVIEW
  • TABLE 334 NXGN MANAGEMENT, LLC.: PRODUCTS OFFERED
  • TABLE 335 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET

List of Figures

  • FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL POPULATION HEALTH MANAGEMENT MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2023-2026
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF POPULATION HEALTH MANAGEMENT MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN POPULATION HEALTH MANAGEMENT MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN POPULATION HEALTH MANAGEMENT MARKET DURING FORECAST PERIOD
  • FIGURE 8 VALUE-BASED CARE AND HEALTHCARE DIGITALIZATION ACCELERATING GROWTH IN POPULATION HEALTH MANAGEMENT MARKET
  • FIGURE 9 SERVICES ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
  • FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 HEALTHCARE DATA BREACH ATTACK VECTORS, 2025
  • FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 15 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 18 PATENT PUBLICATION TRENDS IN POPULATION HEALTH MANAGEMENT MARKET, 2015-2026
  • FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR POPULATION HEALTH MANAGEMENT MARKET
  • FIGURE 20 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2015 TO JULY 2026)
  • FIGURE 21 MARKET POTENTIAL OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT SOLUTIONS ACROSS INDUSTRIES
  • FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 25 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
  • FIGURE 26 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
  • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2021-2025 (USD BILLION)
  • FIGURE 28 POPULATION HEALTH MANAGEMENT: MARKET SHARE ANALYSIS, 2025
  • FIGURE 29 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 30 POPULATION HEALTH MANAGEMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 31 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 32 EV/EBITDA OF KEY VENDORS
  • FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF POPULATION HEALTH MANAGEMENT SOLUTION VENDORS
  • FIGURE 34 POPULATION HEALTH MANAGEMENT MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
  • FIGURE 35 ORACLE: COMPANY SNAPSHOT (2025)
  • FIGURE 36 OPTUM, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
  • FIGURE 38 VERADIGM LLC: COMPANY SNAPSHOT (2025)
  • FIGURE 39 HEALTH CATALYST: COMPANY SNAPSHOT (2025)
  • FIGURE 40 RESEARCH DESIGN
  • FIGURE 41 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 42 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 43 BOTTOM-UP APPROACH
  • FIGURE 44 TOP-DOWN APPROACH
  • FIGURE 45 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POPULATION HEALTH MANAGEMENT SOLUTIONS INDUSTRY
  • FIGURE 46 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 47 DATA TRIANGULATION METHODOLOGY